Crystal structure of the human prion protein reveals a mechanism for oligomerization

The pathogenesis of transmissible encephalopathies is associated with the conversion of the cellular prion protein, PrPC, into a conformationally altered oligomeric form, PrPSc. Here we report the crystal structure of the human prion protein in dimer form at 2 Å resolution. The dimer results from the three-dimensional swapping of the C-terminal helix 3 and rearrangement of the disulfide bond. An interchain two-stranded antiparallel β-sheet is formed at the dimer interface by residues that are located in helix 2 in the monomeric NMR structures. Familial prion disease mutations map to the regions directly involved in helix swapping. This crystal structure suggests that oligomerization through 3D domain-swapping may constitute an important step on the pathway of the PrPC → PrPSc conversion.

[1]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[2]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[3]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[4]  W. Surewicz,et al.  The Role of Disulfide Bridge in the Folding and Stability of the Recombinant Human Prion Protein* , 2001, The Journal of Biological Chemistry.

[5]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[6]  W. Surewicz,et al.  Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.

[7]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[8]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[9]  E J Dodson,et al.  Collaborative Computational Project, number 4: providing programs for protein crystallography. , 1997, Methods in enzymology.

[10]  D. Eisenberg,et al.  Domain swapping: entangling alliances between proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K Wüthrich,et al.  NMR structure of the bovine prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[13]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[14]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[15]  B. Chesebro,et al.  A 60-kDa Prion Protein (PrP) with Properties of Both the Normal and Scrapie-associated Forms of PrP (*) , 1995, The Journal of Biological Chemistry.

[16]  Zbigniew Grzonka,et al.  Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping , 2001, Nature Structural Biology.

[17]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[18]  W. Surewicz,et al.  Solution Structure of the E200K Variant of Human Prion Protein , 2000, The Journal of Biological Chemistry.

[19]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[20]  P E Wright,et al.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K Wüthrich,et al.  Human prion proteins expressed in Escherichia coli and purified by high‐affinity column refolding , 1997, FEBS letters.

[22]  F. Cohen,et al.  Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Thomas C. Terwilliger,et al.  Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.

[24]  C. Chothia,et al.  The atomic structure of protein-protein recognition sites. , 1999, Journal of molecular biology.

[25]  R M Esnouf,et al.  Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.

[26]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[27]  A. Parente,et al.  The dual-mode quaternary structure of seminal RNase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Surewicz,et al.  Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. , 2000, Biochemistry.

[30]  G. Bricogne,et al.  [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. , 1997, Methods in enzymology.

[31]  Arthur L Horwich,et al.  Deadly Conformations—Protein Misfolding in Prion Disease , 1997, Cell.